https://www.selleckchem.com/pr....oducts/bromopyruvic-
as a novel treatment for GBM. Our results demonstrate that a promoter-targeted dsRNA can silence or promote gene transcription depending on its targeted site in different cis-acting elements in the gene promoter. Targeted inhibition of GDNF by enhancer II-targeted dsRNA may be explored as a novel treatment for GBM.The choice of a (bio)material plays a crucial role in the development of a drug delivery system because it confers specific biopharmaceutical properties to the formulation and modulates the pharmacokinetic and pharma
Respect!
Kommentar
Delen
